CVS HEALTH Corp Quarterly Report for Q1 Ended Mar 31, 2023

Summary

CVS Health Corporation reported strong revenue growth of 11.0% year-over-year for the first quarter of 2023, reaching $85.3 billion. This increase was primarily driven by growth in its Products and Premiums segments. However, net income saw a decrease of 9.3% to $2.14 billion, or $1.65 per diluted share, compared to the prior year period. The company completed the acquisition of Signify Health for $7.4 billion in late March, significantly increasing its goodwill and intangible assets, and also announced the acquisition of Oak Street Health for $10.6 billion in early May. Operationally, the company recorded a $349 million loss on assets held for sale related to its Omnicare long-term care business. The company also noted a significant increase in net cash provided by operating activities, largely due to the early receipt of CMS payments. Despite the dip in net income, the company's strategic acquisitions and continued revenue growth across its segments signal a focus on expanding its health services capabilities and value-based care offerings.

Key Highlights

• 1Total revenues increased by 11.0% to $85.3 billion in Q1 2023 compared to Q1 2022.
• 2Net income attributable to CVS Health decreased by 9.3% to $2.14 billion in Q1 2023, with diluted EPS at $1.65.
• 3The company completed the acquisition of Signify Health for $7.4 billion on March 29, 2023, adding to its Health Services segment.
• 4A loss on assets held for sale of $349 million was recorded for the Omnicare long-term care business.
• 5Net cash provided by operating activities significantly increased to $7.4 billion in Q1 2023 from $3.6 billion in Q1 2022.
• 6The company repurchased $2.0 billion of common stock in Q1 2023.
• 7CVS Health announced the $10.6 billion acquisition of Oak Street Health on May 2, 2023.

Frequently Asked Questions